Suppr超能文献

Reply to Yang et al.: Tocilizumab treatment in COVID-19 patients needs the assessment of the disease severity and timely intervention.

作者信息

Xu Xiaoling, Han Mingfeng, Li Tiantian, Sun Wei, Wang Dongsheng, Fu Binqing, Zhou Yonggang, Zheng Xiaohu, Yang Yun, Li Xiuyong, Zhang Xiaohua, Pan Aijun, Wei Haiming

机构信息

Respiratory and Critical Care Medicine, The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital), Hefei 230000, People's Republic of China;

Respiratory and Critical Care Medicine, Anhui Fuyang Second People's Hospital, Fuyang 230000, People's Republic of China.

出版信息

Proc Natl Acad Sci U S A. 2020 Dec 1;117(48):30027-30028. doi: 10.1073/pnas.2011616117. Epub 2020 Nov 12.

Abstract
摘要

相似文献

1
Reply to Yang et al.: Tocilizumab treatment in COVID-19 patients needs the assessment of the disease severity and timely intervention.
Proc Natl Acad Sci U S A. 2020 Dec 1;117(48):30027-30028. doi: 10.1073/pnas.2011616117. Epub 2020 Nov 12.
2
[COVID-19: Still a place for tocilizumab?].
Rev Med Interne. 2021 Feb;42(2):73-78. doi: 10.1016/j.revmed.2020.11.016. Epub 2020 Nov 27.
5
Tocilizumab for Covid-19 - The Ongoing Search for Effective Therapies.
N Engl J Med. 2020 Dec 10;383(24):2387-2388. doi: 10.1056/NEJMe2032071.
6
Does tocilizumab have a magical therapeutic effect on COVID-19 patients without obvious adverse reactions?
Proc Natl Acad Sci U S A. 2020 Dec 8;117(49):30896-30897. doi: 10.1073/pnas.2009961117. Epub 2020 Nov 17.
8
A retrospective evaluation of COVID-19 patients treated with Tocilizumab: who should be treated?
J Infect Dev Ctries. 2021 Dec 31;15(12):1825-1832. doi: 10.3855/jidc.13498.

本文引用的文献

1
Safety concerns regarding concomitant use of tocilizumab and glucocorticoids in COVID-19 patients.
Proc Natl Acad Sci U S A. 2020 Dec 1;117(48):30025-30026. doi: 10.1073/pnas.2009253117. Epub 2020 Nov 12.
2
Tocilizumab for the treatment of severe coronavirus disease 2019.
J Med Virol. 2020 Oct;92(10):2042-2049. doi: 10.1002/jmv.25964. Epub 2020 May 10.
4
Effective treatment of severe COVID-19 patients with tocilizumab.
Proc Natl Acad Sci U S A. 2020 May 19;117(20):10970-10975. doi: 10.1073/pnas.2005615117. Epub 2020 Apr 29.
5
Use of Tocilizumab for COVID-19-Induced Cytokine Release Syndrome: A Cautionary Case Report.
Chest. 2020 Jul;158(1):e15-e19. doi: 10.1016/j.chest.2020.04.024. Epub 2020 Apr 25.
6
Tocilizumab treatment in COVID-19: A single center experience.
J Med Virol. 2020 Jul;92(7):814-818. doi: 10.1002/jmv.25801. Epub 2020 Apr 15.
7
Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury.
Lancet. 2020 Feb 15;395(10223):473-475. doi: 10.1016/S0140-6736(20)30317-2. Epub 2020 Feb 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验